Invasive micropapillary carcinoma of the breast and invasive breast carcinoma of no
special type: a comparison of claudin proteins' expression and its impact on survival
Invasive micropapillary carcinoma of the breast is characterized by clusters of cells
presenting with inverted polarity. Although the apico-basal polarity is a fundamental
property of the epithelium, the biological alterations leading to the inside-out pattern
observed in invasive micropapillary carcinoma (IMPC) remain mostly unknown. The regulation
of tight junctions in polarity formation and maintenance is acknowledged. By using
immunohistochemistry, we have analysed claudin-1, -3, -4, and -7 tight junction proteins
expression and their prognostic value on IMPCs and compared them to invasive breast
carcinomas of no special type (IBC-NST) tumors. Our cohort consisted of 37 IMPCs,
36 IBC-NST and 9 mixed IMPC/IBC-NST tumors. Two scoring systems were used to quantify
protein expression: a 4-tier scoring system and the H-score method. Distant metastasis
free survival (DMFS) intervals and overal survival (OS) data were used for prognosis
evaluation. The analysed samples were characterized mainly by low or no claudin-1
expression whereas claudins-3, -4 and -7 showed variable positivity. We have found
no significant differences in claudin-3 and -4 protein expression between IMPC and
IBC-NST groups with either scoring methods, however high claudin-7 expression was
found in significantly more IMPCs than IBC-NST tumors according to the H-score system
(p = 0.02). The 4-tier scoring method revealed association of claudin-7 expression
with molecular tumor subtypes (p = 0.001). IMPC and IBC-NST tumors did not show difference
in DMFS (p = 0.70). In the analysis of pure IMPC and IBC-NST tumors, positive/high
claudin-4 protein expression was significantly associated with shorter DMFS (p = 0.02/p
= 0.008, respectively according to the two scoring methods). Claudin-3 and claudin-7
expression showed no association with DMFS or OS. Changes in epithelial polarity seem
not to be related to claudin-1, -3, and -4 expression. Increased claudin-4 expression
may have a role in breast cancer progression.